Rockwell Medical Inc.

NASDAQ: RMTI · Real-Time Price · USD
1.01
-0.04 (-3.81%)
At close: Aug 15, 2025, 2:17 PM

Rockwell Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
16.07M 18.91M 24.66M 28.32M 25.83M 22.68M 22.09M 23.77M 18.08M 19.67M 19.31M 18.69M 18.68M 16.12M 15.33M 15.99M 15.14M 15.47M
Cost of Revenue
13.57M 15.87M 21.03M 22.08M 21.28M 19.61M 19.22M 21.57M 17.05M 17.07M 16.97M 17.91M 16.94M 16.91M 17.56M 16.32M 15.4M 15.07M
Gross Profit
2.5M 3.04M 3.63M 6.24M 4.55M 3.06M 2.87M 2.2M 1.03M 2.6M 2.34M 777K 1.75M -786K -2.23M -329K -262K 401K
Operating Income
-1.35M -1.36M -519K 1.94M 515K -1.32M -547K -1.74M -2.96M -1.43M -1.97M -3.71M -4.48M -6.63M -8.36M -6.97M -7.82M -7.18M
Interest Income
69K 66K 29K 30K 9K 24K 42K 56K 49K 64K 45K n/a n/a n/a 5K n/a 7K 11K
Pretax Income
-1.49M -1.51M -756K 1.66M 343K -1.73M -1.51M -1.87M -3.31M -1.75M -2.36M -4.19M -4.97M -7.16M -8.94M -7.58M -8.4M -7.75M
Net Income
-1.49M -1.51M -756K 1.66M 343K -1.73M -1.51M -1.87M -3.31M -2.46M -2.75M -4.67M -5.45M -7.7M -8.94M -7.58M -8.4M -7.75M
Selling & General & Admin
3.85M 4.4M 4.15M 4.3M 4.04M 4.37M 3.25M 3.44M 3.83M 3.75M 4.15M 4.02M 5.3M 4.27M 4.74M 5.42M 5.14M 5.77M
Research & Development
n/a n/a 1K n/a n/a 18K 168K 494K 167K 278K 156K 469K 926K 1.57M 1.39M 1.22M 2.42M 1.81M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
3.85M 4.4M 4.15M 4.3M 4.04M 4.39M 3.42M 3.94M 3.99M 4.03M 4.31M 4.49M 6.23M 5.84M 6.13M 6.64M 7.56M 7.58M
Interest Expense
-276K 277K 289K 302K 232K 431K 1.11M 411K 395K 387K 439K 482K 485K 540K 588K 609K 583K 581K
Selling & Marketing Expenses
572K 711K 843K 726K 586K 594K 541K 556K 530K 498K 352K 762K 526K 455K 873K 1.54M 1.47M 1.85M
Cost & Expenses
17.42M 20.27M 25.18M 26.38M 25.32M 24M 22.64M 25.51M 21.04M 21.09M 21.28M 22.4M 23.16M 22.75M 23.69M 22.96M 22.96M 22.66M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 710K 394K 482K 485K 536K n/a n/a n/a 11K
Shares Outstanding (Basic)
34.31M 34.11M 32.88M 31.55M 30.45M 29.33M 28.65M 27.52M 18.5M 18.36M 11.55M 10.53M 8.81M 8.54M 8.53M 8.53M 8.48M 8.51M
Shares Outstanding (Diluted)
34.31M 34.11M 32.88M 32.42M 32.03M 29.33M 28.65M 27.52M 18.5M 18.36M 11.55M 10.53M 8.81M 8.55M 8.53M 8.53M 8.52M 8.51M
EPS (Basic)
-0.05 -0.04 -0.02 0.05 0.01 -0.06 -0.05 -0.07 -0.18 -0.13 -0.24 -0.44 -0.62 -0.9 -1.05 -0.89 -0.99 -0.91
EPS (Diluted)
-0.05 -0.04 -0.02 0.05 0.01 -0.06 -0.05 -0.07 -0.18 -0.13 -0.24 -0.44 -0.62 -0.9 -1.05 -0.89 -0.99 -0.91
EBITDA
-1.35M -1.36M 75K 2.51M 1.12M -755K 146K -897K -2.74M -718K -1.27M -3.56M -4.34M -6.48M -7.68M -6.37M -7.19M -6.56M
EBIT
n/a -1.24M -466K 1.97M 575K -1.3M -404K -1.46M -2.91M -1.36M -1.93M -3.71M -4.48M -6.62M -8.35M -6.97M -7.82M -7.17M
Depreciation & Amortization
n/a 539K 541K 543K 549K 545K 550K 564K 702K 645K 649K 634K 648K 658K 668K 605K 628K 614K